Jack NGUYEN,David CHERNOFF,Sangita GHOSH,Gregory T. WENT,Timothy J. FULTZ
申请号：
US15863746
公开号：
US20180161282A1
申请日:
2018.01.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Compositions and methods are provided for administering a pharmaceutical composition to a human patient. Compositions are administered to a human patient orally, once daily, at a therapeutically effective dose. The pharmaceutical compositions comprise a drug selected from the group consisting of brivaracetam, divalproex, lacosamide, levetiracetam, oxcarbazepine, vigabatrin, and pharmaceutically acceptable salts of any of the foregoing, and at least one excipient. At least one of said at least one excipients modifies the release of said drug to provide an extended release form. The pharmaceutical composition have pharmacokinetic properties recited in the claims.
